32 Participants Needed

Mobile App for Reducing Pain and Heavy Drinking

TP
MK
Overseen ByMaya Kratzer, BA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Boston University Charles River Campus
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I have to stop taking my current medications for the trial?

You can continue taking your current medications if you have been on the same dose for at least 2 months and are willing to keep using them as prescribed during the trial.

What data supports the effectiveness of the treatment mhealth-pc for reducing pain and heavy drinking?

Research shows that smartphone apps can help reduce alcohol consumption, as seen in studies where apps like A-CHESS and LBMI-A promoted self-reported reductions in alcohol use. Additionally, a study found that a mobile health app combined with motivational interviewing was effective in reducing drinking among college students.12345

Is the mobile app for reducing pain and heavy drinking safe for humans?

The research on mobile apps for reducing alcohol consumption suggests they are generally safe, with users finding them easy to use and helpful in increasing awareness about alcohol use. However, more systematic evaluations are needed to ensure their clinical usefulness.12367

How is the mhealth-pc treatment different from other treatments for reducing pain and heavy drinking?

The mhealth-pc treatment is unique because it uses a mobile app to provide real-time feedback and support, which can be more accessible and engaging than traditional in-person interventions. This approach leverages smartphone technology to help users self-manage their drinking habits and pain, potentially offering greater reach and convenience.138910

What is the purpose of this trial?

Chronic pain and heavy drinking are common co-occurring conditions among patients presenting to primary care settings. Given their impact on functioning and medical outcomes, there would be considerable benefit to developing an accessible, easily utilized, integrative approach to reduce alcohol use and pain that can be readily incorporated into the health care settings. The objective of this study is to test a modified version of a smartphone-based intervention for reducing pain and alcohol use among individuals experiencing chronic pain who engage in heavy drinking. The primary goal is to test the feasibility and acceptability of implementing this intervention in a sample that includes participants from rural areas and providing initial data on the utility of the intervention.

Eligibility Criteria

This trial is for individuals who experience chronic pain and engage in heavy drinking. It's designed to test a smartphone-based intervention aimed at reducing both pain and alcohol consumption. Participants from rural areas are included to provide diverse data on the intervention's utility.

Inclusion Criteria

Heavy drinking by NIAAA guidelines (weekly limits [> 7 standard drinks for women or men age 65+, > 14 for men younger than 65], and/or a heavy drinking episode in the past month [>3 for women or men age 65+, > 4 for men younger than 65]) or by a positive USAUDIT-C score
I have had chronic pain for at least 3 months, rated 4 or higher.

Exclusion Criteria

Patients with bipolar disorder, schizophrenia, other psychotic disorder, or current suicidal intent
I have pain related to my cancer.
If on medication for pain or alcohol, not on same dose for at least 2 months
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a smartphone-based intervention for reducing pain and alcohol use

8 weeks
Mobile app usage

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
Assessment at 12 weeks following baseline

Treatment Details

Interventions

  • mhealth-pc
Trial Overview The study is testing 'mhealth-pc', a mobile app-based approach, to see if it can help people with chronic pain reduce their hazardous drinking habits. The focus is on how feasible and acceptable this technology is for patients in primary care settings.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Mobile App InterventionExperimental Treatment1 Intervention
Mobile health intervention delivered through an app
Group II: ControlActive Control1 Intervention
Assessment Only Control condition

Find a Clinic Near You

Who Is Running the Clinical Trial?

Boston University Charles River Campus

Lead Sponsor

Trials
125
Recruited
14,100+

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator

Trials
865
Recruited
1,091,000+

Findings from Research

A review identified six smartphone apps aimed at reducing alcohol consumption or treating alcohol use disorder (AUD), with only two apps (A-CHESS and LBMI-A) showing self-reported reductions in alcohol use.
The study highlights a significant gap in the evaluation of these apps, indicating that while smartphone technology has potential for aiding individuals with AUD, more rigorous testing is needed to confirm their effectiveness.
Smartphone applications to reduce alcohol consumption and help patients with alcohol use disorder: a state-of-the-art review.Meredith, SE., Alessi, SM., Petry, NM.[2022]
A survey of 139 participants showed strong interest in using a mobile health application that monitors blood alcohol concentration (BAC) through gait analysis, indicating potential for reducing risky drinking behaviors.
Participants expressed a desire for control over app features, with adults preferring the option to disable BAC monitoring, while females favored mandatory notifications and safety features, highlighting the importance of user preferences in app design.
User-centered preferences for a gait-informed alcohol intoxication app.Borges, A., Caviness, C., Abrantes, AM., et al.[2023]
The study involving 379 college students showed that a smartphone app combined with Brief Motivational Interviewing (BMI) effectively reduced alcohol consumption and related consequences, particularly in voluntary participants.
In a controlled trial, participants using the app had a decrease in peak Blood Alcohol Concentration (BAC) compared to those receiving only in-person BMI, highlighting the app's potential as a beneficial tool for alcohol intervention.
Effectiveness of a Theory-Based mHealth Intervention for High-Risk Drinking in College Students.Kazemi, DM., Borsari, B., Levine, MJ., et al.[2021]

References

Smartphone applications to reduce alcohol consumption and help patients with alcohol use disorder: a state-of-the-art review. [2022]
User-centered preferences for a gait-informed alcohol intoxication app. [2023]
Effectiveness of a Theory-Based mHealth Intervention for High-Risk Drinking in College Students. [2021]
Inventory and Analysis of Controlled Trials of Mobile Phone Applications Targeting Substance Use Disorders: A Systematic Review. [2021]
Keeping Track of My Drinking - Patient Perceptions of Using Smartphone Applications as a Treatment Complement for Alcohol Dependence. [2023]
U.S. veterans' experiences and factors associated with use of a smartphone application to self-manage unhealthy alcohol use. [2023]
Delivering Personalized Protective Behavioral Drinking Strategies via a Smartphone Intervention: a Pilot Study. [2020]
Using a mobile health application to reduce alcohol consumption: a mixed-methods evaluation of the drinkaware track & calculate units application. [2022]
The effectiveness of a mobile intervention to reduce young adults' alcohol consumption to not exceed low-risk drinking guidelines. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
A combined laboratory and field test of a smartphone breath alcohol device and blood alcohol concentration estimator to facilitate moderate drinking among young adults. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity